GOVERNMENTAL VCs whose dedicated mission is to fund early stage Biopharma, and fill the yawing void that VCs have left in this sector is an idea whose time has come due. Every country can shave off some stimulus money for this important stimulus of one of the greatest economic engines in recent history.